Cardiac resynchronization therapy (CRT) is an important and effective therapy for end-stage
heart failure. Non-response to CRT is one of the main obstacles to its application in clinical …

Cardiac resynchronization therapy (CRT) is an evidence-based effective therapy of
symptomatic heart failure with reduced ejection fraction refractory to optimal medical …

Cardiac resynchronization therapy (CRT) has revolutionized the care of the patients with
heart failure with reduced ejection fraction and electrical dyssynchrony. The current …

Background Cardiac resynchronization therapy (CRT) is a successful strategy for heart
failure (HF) patients. The pre-requisite for the response is the evidence of electrical …

Heart failure (HF) is a critical health issue. Despite the advancements in pharmacotherapy,
HF-related morbidity and mortality remains high. Cardiac resynchronization therapy (CRT) …

Although cardiac resynchronization therapy (CRT) is a well-established treatment for a
subset of patients with chronic heart failure, a considerable proportion of eligible patients still …

Cardiac resynchronisation therapy (CRT) has been increasingly accepted as an adjunct
therapy to drug treatment for heart failure patients with ventricular conduction delay …

Aims A variable proportion, up to 30%, of patients who undergo cardiac resynchronization
therapy (CRT) do not benefit from treatment. The aim of the Cardiac Resynchronization …

Introduction: Cardiac resynchronization therapy (CRT) is now an established
nonpharmacologic therapy for advanced heart failure with electromechanical delay. Despite …

Background Approximately 30% of patients treated with cardiac resynchronization therapy
(CRT) do not achieve favourable response. The purpose of the present study was to identify …